Events

Briefing on Understanding Environmental Exposures and Cancer: The Case of Multiple Myeloma

myelnoma 22

Please join the International Myeloma Foundation for a Congressional Briefing to discuss research on the links between exposure to environmental factors and multiple myeloma. Multiple myeloma is a rare blood cancer and this year, approximately 22,000 Americans will be diagnosed and about 11,000 will die from the disease.

Recent research has indicated that there are certain populations who have higher rates of developing multiple myeloma, including first respondents at the World Trade Center site, farmers, and other persons with jobs that have environmental exposures to chemicals. In fact, a new update from the World Trade Center Health Program at Mount Sinai Hospital combined with data from the New York City Fire Department indicated that 2,518 first responders have now developed cancer and myeloma is among the top four cancers reported. These myeloma cases have been attributed to exposure to 1-3 Butadiene, an industrial chemical used to produce synthetic rubber that is a known cancer-causing agent, which was found at the World Trade Center site.

Speakers at the briefing will discuss the latest research findings and share their personal stories about their experience with multiple myeloma. The audience will learn about multiple myeloma, opportunities to further research, potential environmental risk factors for multiple myeloma, and efforts among patient advocates, industry, researchers and policy makers to reduce potential exposure to environmental toxins associated with myeloma.

RSVP to Zara Day at crdfellow2@dc-crd.com or 202.484.1100.

Speakers include:

  •  Dr. Ola Landgren
    Attending Physician and Chief of the Myeloma Service, at Memorial Sloan Kettering Hospital, and former Chief of the Multiple Myeloma Section at the National Cancer Institute, will discuss research concerning links between environmental exposures and myeloma.
  • Dr. Laura Crowley
    Assistant Clinical Professor, Preventive Medicine at Mt. Sinai Hospital and Senior Physician in the World Trade Center program, will discuss her research on the increased prevalence of multiple myeloma observed in World Trade Center (WTC) responders registered in the WTC Medical Program.
  • Ms. Patricia Workman
    Will share personal experience as a volunteer at the World Trade Center site and subsequent diagnosis of myeloma.